Article and Video CATEGORIES

Cancer Journey

Search By

Choices Among Immunotherapeutics May Be the Future of Lung Cancer Care
Author
GRACE Videos and Articles

ASCO 2015 Highlights 03

 

Novel immunotherapy agent atezolizumab (MPDL3280A) looks superior to Taxotere (docetaxel) in a study, specifically for patients with PD-L1. What are the implications of multiple agents with similar mechanisms of action in the same clinical settings?

[powerpress]

Download Transcript

Please feel free to offer comments and raise questions in our Discussion Forums.

 

Next Previous link

Previous PostNext Post